Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Biogen Inc (BIIB)

277.67 -2.73 (-0.97%)

05-21 16:00

Open:

281.36

Pre. Close:

280.4

High:

282.045

Low:

276.44

Volume:

1,181,813

Market Cap:

58591M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

282.36 - 284.66

284.66 - 286.205

Low:

271.649 - 274.196

274.196 - 275.906

Close:

274.346 - 278.279

278.279 - 280.919

Technical analysis  (as of: 2018-05-21 4:27:11 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 333.49     One year: 389.51

Support:

Support1: 263.06    Support2: 249.17

Resistance:

Resistance1: 285.52    Resistance2: 333.49

Pivot:

275.59

Moving Averages:

MA(5): 279.24     MA(20): 274.49

MA(100): 296.18     MA(250): 298.37

MACD:

MACD(12,26): 2.35     Signal(12,26,9): 1.46

%K %D:

%K(14,3): 72.20     %D(3): 74.30

RSI:

RSI(14): 53.66

52-Week:

High: 370.57  Low: 244.28  Change(%): 11.9

Average Vol(K):

3-Month: 176598  10-Days 153572

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BIIB has closed below upper band by 39.5%. Bollinger Bands are 36.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-21T11:57:48-04:00
A Quantitative System To Invest In Quality Stocks

2018-05-18T12:03:36-04:00
J&J bails on Alzheimer's candidate atabecestat on toxicity issues

2018-05-18T08:21:17-04:00
Investors bullish on biotechs after Trump drug pricing speech

2018-05-15T13:01:44-04:00
Scholar Rock Readies $75 Million IPO

2018-05-14T12:27:31-04:00
Oryzon Genomics commences mid-stage study of Alzheimer's candidate

2018-05-11T14:25:19-04:00
Trump speech on drug prices light on specifics

2018-05-11T10:22:19-04:00
Trump plan on drug prices to be announced this afternoon

2018-05-11T07:38:21-04:00
FANG Stocks Have Ignited A Rally - Cramer's Mad Money (5/10/18)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

211.01

Shares Float (M)

209.08

% Held by Insiders

0.90

% Held by Institutions

94.30

Shares Short (K)

3446

Shares Short Prior Month (K)

2560

Stock Financials

EPS

22.660

EPS Est. Current Year

22.100

EPS Est. Next Year

23.820

EPS Est. Next Quarter

5.780

Forward EPS

26.145

Book Value (p.s.)

4.240

PEG Ratio

1.84

Profit Margin

24.89

Operating Margin

49.37

Return on Assets (ttm)

12.5

Return on Equity (ttm)

23.2

Qtrly Rev. Growth

11.4

Gross Profit (p.s.)

38.945

Sales Per Share

EBITDA (p.s.)

23.456

Qtrly Earnings Growth

56.90

Operating Cash Flow (M)

5770.00

Levered Free Cash Flow (M)

3920.00

atoplab.com

Valuation

P/E

12.25

P/E Growth Ratio

-0.01

P/BV

65.49

P/S

984228928.00

P/CF

10.15

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.